Forward Pharma A/S (FWPAY)
Stock analysis · OTC · Healthcare · Biotechnology
$300.00
Market Cap
$7.45M
PE (TTM)
-3.88
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
1.02
Day Range
$300.00 – $300.00
52-wk Range
$200.00 – $882.86
Avg Volume
N/A
Volume
4.00
Forward Pharma A/S (FWPAY) is a publicly traded company in the Healthcare sector. Latest price: $300.00. Market cap $7.45M. Trailing PE -3.88. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Earnings
Most Recent
Apr 18, 2017
EPS $-1.75 vs est. $-2.12
Beat by $0.37
Proprietary Signals
About Forward Pharma A/S
Forward Pharma A/S presently engages in very limited business activities. In the past, this biopharmaceutical firm concentrated its efforts on developing FP187, its distinctive formulation of dimethyl fumarate, which was aimed at addressing both inflammatory and neurological conditions. The company was founded in 2005 and its headquarters are located in Copenhagen, Denmark.
Valuation
| P/E (TTM) | -3.88× |
|---|---|
| P/S (TTM) | 0.00× |
| P/B | 0.10× |
| PEG | 0.05× |
| P/FCF (TTM) | -3.16× |
| EV / EBITDA | 33.47× |
| EV / Sales | 0.00× |
| Earnings Yield | -25.80% |
| Free Cash Flow Yield | -31.68% |
Fundamentals
| Enterprise Value | -$63.32M |
|---|---|
| Net Income (TTM) | -$1.92M |
| Free Cash Flow (TTM) | -$2.36M |
| Net Debt | -$70.77M |
| Working Capital | $70.79M |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | -2.53% |
| Return on Invested Capital | -5.47% |
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap